
Complaints against medical schemes rise by 24.6%
The CMS’s 2025/26 annual report also highlights progress on a costed primary healthcare benefits package and research into linking administrator fees to outcomes.

The CMS’s 2025/26 annual report also highlights progress on a costed primary healthcare benefits package and research into linking administrator fees to outcomes.

Most members will face increases of 7% or less, while the scheme is adding benefits in mental health, maternity, preventive care, and emergency treatment.

The scheme is pairing the increase with changes to Health4Me and a broader push into prevention, wellness, and digital healthcare.

The scheme is adding a R1 000 healthcare benefit, expanding preventative care, and making targeted changes to medicine, casualty, and clinical cover.

The industry body says the 3.8% benchmark does not fully reflect the utilisation and underlying healthcare-cost pressures that schemes face.

Global medical cost growth is easing, but South Africa’s rate remains high – putting medical schemes under pressure to balance rising healthcare costs with affordability in 2027.

Parliamentary questions extend from fraud and outsourcing to trustee remuneration and benefit design, while the scheme’s reserves remain below the statutory requirement.

DENOSA says the lack of disclosure over Stan Moloabi’s suspension raises wider questions about the scheme’s leadership, accountability, and handling of member concerns.

The regulator has clarified the scope of its oversight of Bonitas, confirming that two separate regulatory processes are under way.

Medscheme says the CMS has broadened its investigation into Bonitas’s procurement processes, but Bonitas disputes that interpretation.

The scheme says R1.7 billion in projected savings could moderate future increases as it prepares for robust talks with organised labour.

The CMS argues that a 7.5% increase would have weakened GEMS’s financial sustainability and shifted costs to members in future.

The regulator says it is monitoring the situation and sees signs of improvement, but some members continue to report difficulties accessing healthcare and resolving claims.

The regulator has rejected the scheme’s proposal to reduce its weighted average contribution adjustment to 7.5%, leaving the existing 9.5% increase in place.

A review of five years of Medihelp’s annual reports traces the events behind the scheme’s fall below and its rise back above the statutory minimum.

Twelve months after reporting a solvency ratio of just 20.99%, Medihelp returned above the statutory threshold while almost nine-folding its operating surplus.

The ruling preserves a key anti-fraud tool that industry bodies say protects member funds and helps contain healthcare costs.